BREAKING
Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 4 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 6 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 8 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 10 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 11 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 11 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 12 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 14 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 4 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 6 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 8 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 10 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 11 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 11 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 12 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 14 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 14 hours ago
ADVERTISEMENT
Market News

Uxin Limited (UXIN): Q3 2019 Earnings Snapshot

— Uxin Limited (NASDAQ: UXIN) reported Q3 2019 loss of RMB0.30, or $0.04 per share, vs. $0.14 expected. — Revenues grew 33.4% to RMB461.4 million, or $65.2 million, vs. $135 million expected. — 2C revenue was RMB327.5 million, or $46.3 million, up 246.9% year-over-year. — 2B revenue was RMB71.7 million, or $10.1 million, down 62.5% […]

$UXIN November 27, 2019 1 min read

— Uxin Limited (NASDAQ: UXIN) reported Q3 2019 loss of RMB0.30, or $0.04 per share, vs. $0.14 expected.

— Revenues grew 33.4% to RMB461.4 million, or $65.2 million,
vs. $135 million expected.

— 2C revenue was RMB327.5 million, or $46.3 million, up 246.9%
year-over-year.

— 2B revenue was RMB71.7 million, or $10.1 million, down 62.5%
year-over-year.

— 2C transaction volume increased 107.3% to 23,566 units.

ADVERTISEMENT

— 2B transaction volume decreased 66.6% to 30,658 units.  

— 2C GMV increased to RMB2,828 million, representing a
year-over-year growth of 110.0%.

 — 2B GMV decreased
to RMB1,537 million, representing a year-over-year decline of 64.1%.

— Q4 2019 total revenues are estimated to be RMB540 million to RMB560 million.

— Q4 2019 adjusted loss from continuing operations are projected to be RMB150 million to RMB170 million.

ADVERTISEMENT

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

ADVERTISEMENT